Daifuku Co., Ltd. (DFKCY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	9,415	7,739	8,783	6,948	9,122	12,348
Market Cap Growth	3.18%	-11.88%	26.41%	-23.83%	-26.13%	54.08%
Enterprise Value	8,400	6,880	8,476	6,577	8,508	11,961
Last Close Price	12.74	10.29	11.94	8.96	11.90	16.32
PE Ratio	19.71	16.20	29.22	22.39	30.88	42.17
PS Ratio	2.01	1.65	2.17	1.53	2.16	2.88
PB Ratio	3.72	3.05	3.70	2.78	3.79	5.21
P/TBV Ratio	3.84	3.15	3.84	2.88	3.96	5.53
P/FCF Ratio	11.37	9.35	76.41	146.18	23.96	44.42
P/OCF Ratio	9.80	8.06	35.79	46.10	19.54	35.73
EV/Sales Ratio	1.72	1.47	2.10	1.45	2.02	2.79
EV/EBITDA Ratio	11.95	9.96	17.71	12.84	17.75	25.61
EV/EBIT Ratio	13.44	11.20	20.65	14.85	20.56	29.68
EV/FCF Ratio	10.15	8.31	73.74	138.37	22.35	43.02
Debt / Equity Ratio	0.16	0.16	0.20	0.03	0.09	0.13
Debt / EBITDA Ratio	0.58	0.58	0.98	0.17	0.45	0.68
Debt / FCF Ratio	0.49	0.49	4.06	1.81	0.57	1.14
Asset Turnover	-	-	1.02	1.16	1.10	1.11
Inventory Turnover	-	-	7.47	9.17	10.77	11.07
Quick Ratio	2.08	2.08	1.95	1.73	1.88	2.05
Current Ratio	2.48	2.48	2.35	2.14	2.20	2.35
Return on Equity (ROE)	-	-	13.16%	13.21%	13.15%	13.13%
Return on Assets (ROA)	-	-	6.48%	7.11%	6.76%	6.50%
Return on Capital (ROIC)	-	-	10.04%	11.11%	10.21%	9.81%
Return on Capital Employed (ROCE)	20.30%	20.30%	14.30%	16.90%	16.20%	15.00%
Earnings Yield	5.07%	6.17%	3.42%	4.47%	3.24%	2.37%
FCF Yield	8.79%	10.70%	1.31%	0.68%	4.17%	2.25%
Dividend Yield	4.57%	5.01%	2.21%	3.08%	2.08%	1.48%
Payout Ratio	23.29%	23.29%	30.84%	29.05%	29.88%	29.21%
Buyback Yield / Dilution	-2.44%	-1.45%	-1.35%	-0.00%	-0.04%	-0.08%
Total Shareholder Return	2.13%	3.56%	0.87%	3.08%	2.04%	1.40%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.